Weight loss drugs: how will you be affected by the Mounjaro price rise in the UK?

Eli Lilly, the US manufacturer of the weight loss jab Mounjaro, has said the price will rise by 170% in the UK. From September, the price of the drug will increase with a month’s supply of the highest dose rising from £122 to £330.

The change comes as Donald Trump ramps up pressure on drugmakers to increase their prices for Europeans so that they can make them more affordable for Americans.

We’d like to hear from people who use Mounjaro and how the change in cost might affect them. Have you explored switching to a different medication? Are you worried you will have to stop and might put weight back on?

Share your experience

You can tell us how the new price of Mounjaro will affect you by filling in the form below, or messaging us.

Please share your story if you are 18 or over, anonymously if you wish. For more information please see our terms of service and privacy policy.
Your responses, which can be anonymous, are secure as the form is encrypted and only the Guardian has access to your contributions. We will only use the data you provide us for the purpose of the feature and we will delete any personal data when we no longer require it for this purpose. For true anonymity please use our SecureDrop service instead.

If you’re having trouble using the form click here. Read terms of service here and privacy policy here.